Financial News
Latest News about MRK
Recent news which mentions MRK
Avoid Novavax for Now, Until the Picture Clears Up
February 02, 2022
From InvestorPlace
Amendments To Canada's Special Access Program (SAP) Allows Access To Restricted Psychedelic Drugs. How Will This Affect The Industry?
February 02, 2022
From Benzinga
What This FDA News Could Mean for Pfizer
February 01, 2022
From Motley Fool
2 Incredibly Cheap Value Stocks to Buy in February
February 01, 2022
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
January 31, 2022
From Benzinga
From Benzinga
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News
January 31, 2022
From Benzinga
From Motley Fool
This ARK holding and pandemic star is down 77% from its peak — why one hedge fund is starting to buy it
January 31, 2022
From MarketWatch
3 Unstoppable Investments Everyone Needs in Their Portfolios
January 29, 2022
From Motley Fool
Abbott Labs Outlook Cools the Omicron Led Testing Boom
January 28, 2022
From Benzinga
Merck's COVID-19 Pill works Against Omicron, Lab Studies Show
January 28, 2022
Tickers
MRK
From Benzinga
World hits milestone of 10 billion COVID vaccine doses administered, but less than 10% of people in low-income countries have had a first jab
January 28, 2022
From MarketWatch
From Benzinga
From MarketWatch
Say Hello to 2022’s Dogs of the Dow: 10 Dividend Stocks to Watch
January 27, 2022
From InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
January 27, 2022
From Benzinga
U.S. daily COVID case tally now falling and hospitalizations seem to be peaking, as Moderna launches trial of omicron-specific booster
January 27, 2022
From MarketWatch
Jiangsu Recbio Shoots To Become Hong Kong's First HPV Vaccine Stock
January 27, 2022
From Benzinga
The Daily Biotech Pulse: Galapagos Appoints J&J Exec As CEO, Aridis Gets Funding For Antiviral Treatment, Moderna Starts Omicron-Specific Booster Study
January 27, 2022
From Benzinga
From Benzinga
Vaccinex Posts Two Complete Responses In Pepinemab Combo Trial In Head & Neck Cancer
January 26, 2022
From Benzinga
From Motley Fool
2 Stocks to Buy No Matter What Happens in 2022
January 26, 2022
From Motley Fool
Pfizer and BioNTech launch study of omicron vaccine, and FDA halts use of two COVID antibody treatments
January 25, 2022
From MarketWatch
eFFECTOR Secures $50M Funding From Lincoln Park Capital
January 25, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
